These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 26874365

  • 1. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
    Brase J, Finger B, He J, Wirtz K, Stun L, McMillen R, Flynn B.
    Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
    [Abstract] [Full Text] [Related]

  • 2. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley AJ, Kratz JM, Toole JM, Crawford FA, Ikonomidis JS.
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF.
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [Abstract] [Full Text] [Related]

  • 4. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
    Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Ikonomidis JS.
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
    [Abstract] [Full Text] [Related]

  • 5. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

  • 6. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK, Lobato RL, Bartlett B, Klanjac M, Mora-Mangano CT, Soran PD, Oakes DA, Hill CC, van der Starre PJ.
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [Abstract] [Full Text] [Related]

  • 7. Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding.
    Baral P, Cotter E, Gao G, He J, Wirtz K, Sharma A, Zorn Iii T, Muehlebach G, Flynn B.
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2133-2140. PubMed ID: 30772178
    [Abstract] [Full Text] [Related]

  • 8. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 9. Recombinant-activated factor VII in the paediatric cardiac surgery: single unit experience.
    Agarwal V, Okonta KE, Lal PS.
    Afr J Paediatr Surg; 2012 Mar; 9(3):193-7. PubMed ID: 23250238
    [Abstract] [Full Text] [Related]

  • 10. Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study.
    Cotter E, Sharma A, Campton A, Gao G, He J, Wirtz K, Zorn T, Flynn BC.
    Blood Coagul Fibrinolysis; 2021 Oct 01; 32(7):473-479. PubMed ID: 34650021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN.
    Ann Card Anaesth; 2019 Oct 01; 22(4):388-393. PubMed ID: 31621674
    [Abstract] [Full Text] [Related]

  • 14. Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events.
    Brophy GM, Candeloro CL, Robles JR, Brophy DF.
    Ann Pharmacother; 2013 Apr 01; 47(4):447-54. PubMed ID: 23535812
    [Abstract] [Full Text] [Related]

  • 15. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
    Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC.
    Ann Thorac Surg; 2012 Jun 01; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
    [Abstract] [Full Text] [Related]

  • 16. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
    Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.
    J Thorac Cardiovasc Surg; 2012 May 01; 143(5):1198-204. PubMed ID: 22285329
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A, Guinet P, Ruggieri VG, Aymami M, Lelong B, Granry S, Malledant Y, Le Tulzo Y, Gueret P, Verhoye JP, Flecher E.
    Eur J Cardiothorac Surg; 2016 Jan 01; 49(1):78-84. PubMed ID: 25908783
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery.
    Sutherland L, Houchin A, Wang T, Wang S, Moitra V, Sharma A, Zorn T, Flynn BC.
    J Cardiothorac Vasc Anesth; 2022 Jan 01; 36(1):147-154. PubMed ID: 34103218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.